Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice

Inhibition of glucagon signaling causes hyperglucagonemia and pancreatic α cell hyperplasia in mice. We have recently demonstrated that a patient with an inactivating glucagon receptor mutation (P86S) also exhibits hyperglucagonemia and pancreatic α cell hyperplasia but further develops pancreatic n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Run, Dhall, Deepti, Nissen, Nicholas N., Zhou, Cuiqi, Ren, Song-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154424/
https://www.ncbi.nlm.nih.gov/pubmed/21853126
http://dx.doi.org/10.1371/journal.pone.0023397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154424/
https://www.ncbi.nlm.nih.gov/pubmed/21853126
http://dx.doi.org/10.1371/journal.pone.0023397

Ejemplares similares